(VTL) - Earnings & Price History

VTL: - 6.05, $249.02M, 0.15 (2.54%)

Sector: Healthcare - Industry: Biotechnology

Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver that is in Phase III clinical trials to allow the patients own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.Key Statistics

Past VTL reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-07AMC-0.364.254.354.354.254.35-2.30%-2.30%41.05K
2016-11-03AMC-0.325.25555.454.00%4.00%41.17K
2016-08-02AMC-0.336.326.126.636.076.638.33%-4.68%3.27%110.28K
2016-05-09AMC-0.288.638.328.488.188.651.92%1.77%3.73%54.72K
2016-03-08AMC-0.428.788.779.618.459.619.58%-8.64%0.11%192.52K
2015-11-05AMC-0.587.697.998.447.38.445.63%▲-8.89%-3.75%337.59K
2015-05-12AMC-0.6222.7324.522.524.33-7.22%261.90K
2015-03-19AMC-0.5924.8627.3727.4124.3127.50.15%-9.30%-9.17%206.24K
2014-11-13AMCVital Therapies-0.5918.7617.8218.0717.7218.991.40%▲3.82%5.27%101.50K
2014-08-27Vital Therapies-0.6-0.9124.5724.8324.6424.424.82-0.77%-0.28%-1.05%3.60K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades